Early Intervention as a Way of Reducing Neurocognitive Delay in Pediatric Sickle Cell Patients
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early intervention (EI) services benefit children with sickle cell disease (SCD), but are underused. Research is needed to optimize EI strategies for better neurocognitive outcomes in pediatric SCD patients.
Area Of Science
- Pediatric Hematology
- Neurodevelopmental Disorders
- Genetics
Background
- Sickle cell disease (SCD) is a genetic disorder disproportionately affecting African Americans.
- SCD increases the risk of neurocognitive decline and developmental delay in children.
- Early intervention (EI) services are underutilized in pediatric SCD patients despite proven benefits.
Purpose Of The Study
- To investigate the efficacy of specific EI services for pediatric SCD patients.
- To determine if combined EI services yield superior neurocognitive outcomes.
- To identify optimal EI strategies for this population.
Main Methods
- A scoping review was performed using PubMed, Embase, and CINAHL.
- Searches utilized terms related to sickle cell disease and neurocognitive delay.
- Nineteen pediatric-focused articles were selected following PRISMA guidelines.
Main Results
- EI services demonstrate significant benefits for children with SCD.
- Evidence suggests EI positively impacts neurocognitive development in this cohort.
- Optimal timing and specific service combinations require further investigation.
Conclusions
- EI is beneficial for pediatric SCD patients.
- Further research should explore preventative EI and age-related outcomes.
- Optimizing EI can improve neurocognitive trajectories in pediatric SCD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
